Ceredex Value Advisors LLC Acquires Shares of 259,100 Ralliant Corporation $RAL

Ceredex Value Advisors LLC purchased a new position in shares of Ralliant Corporation (NYSE:RAL) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 259,100 shares of the company’s stock, valued at approximately $11,330,000.

A number of other hedge funds and other institutional investors have also modified their holdings of RAL. Arizona State Retirement System boosted its holdings in Ralliant by 1.2% in the third quarter. Arizona State Retirement System now owns 33,566 shares of the company’s stock valued at $1,468,000 after purchasing an additional 413 shares during the last quarter. Manchester Capital Management LLC acquired a new position in shares of Ralliant in the 2nd quarter valued at approximately $29,000. Choreo LLC raised its position in shares of Ralliant by 9.9% in the 3rd quarter. Choreo LLC now owns 6,063 shares of the company’s stock valued at $265,000 after purchasing an additional 546 shares in the last quarter. Westfuller Advisors LLC purchased a new position in shares of Ralliant during the 3rd quarter valued at approximately $26,000. Finally, GAMMA Investing LLC boosted its stake in shares of Ralliant by 57.0% during the 3rd quarter. GAMMA Investing LLC now owns 1,801 shares of the company’s stock valued at $79,000 after buying an additional 654 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on RAL shares. Zacks Research lowered shares of Ralliant from a “hold” rating to a “strong sell” rating in a research note on Monday, February 9th. Morgan Stanley reissued an “overweight” rating and set a $45.00 price objective on shares of Ralliant in a report on Friday, February 6th. Barclays dropped their target price on shares of Ralliant from $60.00 to $52.00 and set an “overweight” rating for the company in a research report on Monday, February 9th. Oppenheimer cut their target price on shares of Ralliant from $60.00 to $50.00 and set an “outperform” rating on the stock in a research note on Friday, February 6th. Finally, Royal Bank Of Canada reduced their price target on shares of Ralliant from $52.00 to $41.00 and set a “sector perform” rating on the stock in a research report on Friday, February 6th. Seven investment analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, Ralliant has an average rating of “Hold” and a consensus target price of $50.50.

Insider Activity

In other news, Director Kevin E. Bryant purchased 1,250 shares of Ralliant stock in a transaction dated Friday, February 6th. The stock was bought at an average price of $39.97 per share, with a total value of $49,962.50. Following the completion of the acquisition, the director owned 4,653 shares in the company, valued at $185,980.41. The trade was a 36.73% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Kate Mitchell purchased 2,350 shares of the stock in a transaction dated Tuesday, February 10th. The shares were purchased at an average price of $42.48 per share, with a total value of $99,828.00. Following the transaction, the director directly owned 8,411 shares of the company’s stock, valued at approximately $357,299.28. The trade was a 38.77% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders purchased 8,145 shares of company stock worth $332,233 over the last 90 days.

Ralliant Trading Down 0.7%

NYSE RAL opened at $44.62 on Wednesday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.58 and a current ratio of 0.84. Ralliant Corporation has a one year low of $37.27 and a one year high of $57.02. The company has a 50-day simple moving average of $48.68 and a 200-day simple moving average of $46.72. The firm has a market capitalization of $4.99 billion and a PE ratio of 22.76.

Ralliant (NYSE:RAL) last released its quarterly earnings data on Wednesday, February 4th. The company reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.67 by $0.02. The business had revenue of $554.60 million for the quarter, compared to analyst estimates of $543.04 million. The company’s revenue for the quarter was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Investors of record on Monday, March 9th will be paid a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, March 9th. Ralliant’s dividend payout ratio is presently 10.20%.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.